收稿日期: 2024-06-14
修回日期: 2024-09-22
网络出版日期: 2025-01-14
基金资助
长沙市市级重点学(专)科建设项目长财社指[2023]95号
Analysis of factors and warning indicators for the intensification of imported malaria in Changsha
Received date: 2024-06-14
Revised date: 2024-09-22
Online published: 2025-01-14
Supported by
Changsha Municipal Key School (Specialized) Construction Project Changcai Shezhi [2023] No. 95
目的 分析长沙市输入性疟疾的特征,结合实验室指标探讨重症疟疾患者的影响因素和早期预警指标。 方法 回顾性分析2012—2023年在长沙市第一医院住院治疗的疟疾患者的病例资料,比较非重症与重症疟疾患者差异,采用双变量相关性-spearman相关系数、logistic回归分析观察指标与重症疟疾的相关性及影响程度,筛选出与预后相关较强的指标,找到疟疾患者进展为重症的独立影响因子,受试者工作特征(ROC)曲线分析各指标及联合检测早期预判重症疟疾的效能,计算曲线下面积(AUC)。 结果 共收集127例疟疾患者的病例资料,其中38例重症疟疾患者、89例非重症患者。与非重症疟疾患者相比,重症疟疾患者发病到住院时间间隔[4.00(2.75,6.00) d]和住院时间[7.00(4.75,12.00) d]更长(Z = -2.20、-3.05,P < 0.05、P < 0.01),出现尿隐血的比例[78.9%(30/38)]更高(χ2 = 18.67,P < 0.01),红细胞数量[4.11(3.46,4.65) × 1012/L]、血小板数量[(53.50 ± 53.73) × 109/L]、白蛋白水平[(34.99 ± 5.36) g/L]更低(Z = -2.37、t = 6.72、t = 4.10,P < 0.05、P < 0.01、P < 0.01),丙氨酸转氨酶(ALT)[53.50(38.63,73.75) U/L]、天冬氨酸转氨酶(AST)[50.85(34.00,97.05) U/L]、乳酸脱氢酶(LDH)[449.50(321.50,625.75) U/L]、总胆红素[(74.18 ± 78.09) μmol/L]、降钙素原(PCT)[2.95(0.91,19.47) ng/ml]水平更高(Z = -3.51、Z = -3.48、Z = -3.58、t = -3.91、Z = -4.63,均P < 0.01)。发病到住院时间间隔、住院时间、尿隐血情况及ALT、AST、总胆红素、LDH、PCT水平等指标与重症疟疾呈正相关(r > 0,均P < 0.05),红细胞数量、血小板数量、白蛋白水平等与重症疟疾呈负相关(r < 0,均P < 0.05),其中血小板数量能较好地反映疾病严重程度(|r| ≥ 0.5,P < 0.01)。尿隐血、AST、总胆红素、LDH、血清肌酐、尿素氮、PCT是重症疟疾的危险因素(OR > 1,P < 0.05),红细胞、血小板、血红蛋白、白蛋白是重症疟疾的保护因素(OR < 1,P < 0.05)。血小板数量、总胆红素是疟疾患者进展为重症的独立影响因子(P < 0.05),AUC分别为0.867、0.769,二者联合检测的AUC为0.900,高于单个指标检测(P < 0.01)。 结论 血小板、总胆红素可作为早期预警重症疟疾的独立影响因子,联合检测较单一检测更有助于重症疟疾的早期预警。
周荃 , 魏超霞 , 蔡春琳 , 李金强 . 长沙市输入性疟疾重症化因素及预警指标分析[J]. 中国寄生虫学与寄生虫病杂志, 2024 , 42(6) : 756 -762 . DOI: 10.12140/j.issn.1000-7423.2024.06.010
Objective To analyze the characteristics of imported malaria in Changsha and explore the influencing factors and early warning indicators of severe malaria patients in combination with laboratory indicators. Methods A retrospective analysis was conducted on the case data of malaria patients hospitalized in the First Hospital of Changsha from 2012 to 2023. Differences between non-severe and severe malaria patients were compared. Bivariate correlation-Spearman correlation coefficient and logistic regression analysis were used to observe the correlation and influence degree between indicators and severe malaria. Indicators strongly related to prognosis were screened to identify independent impact factors for the progression of malaria patients to severe cases. Receiver operating characteristic (ROC) curve analysis was performed to assess the efficacy of individual and combined indicators in early prediction of severe malaria, and the area under the curve (AUC) was calculated. Results Case data from 127 malaria patients were collected, which including 38 severe malaria patients and 89 non-severe patients. Compared with non-severe malaria patients, severe malaria patients had longer durations from onset to hospitalization [4.00 (2.75, 6.00) d] and longer hospitalization time [7.00 (4.75, 12.00) d] (Z = -2.20, -3.05, P < 0.05, P < 0.01). More severe malaria patients [78.9% (30/38)] were presenting with occult blood in urine (χ2 = 18.67, P < 0.01). They had lower red blood cell count [4.11 (3.46, 4.65) × 1012/L], platelet count [(53.50 ± 53.73) × 109/L] and albumin level [(34.99 ± 5.36) g/L] (Z = -2.37, t = 6.72, t = 4.10; P < 0.05, P < 0.01, P < 0.01), but higher levels of alanine aminotransferase (ALT) [53.50 (38.63, 73.75) U/L], aspartate aminotransferase (AST) [50.85 (34.00, 97.05) U/L], lactate dehydrogenase (LDH) [449.50 (321.50, 625.75) U/L], total bilirubin [(74.18 ± 78.09) μmol/L] and procalcitonin (PCT) [2.95 (0.91, 19.47) ng/ml] (Z = -3.51, Z = -3.48, Z = -3.58, t = -3.91, Z = -4.63; all P < 0.01) than non-severe patients. Durations from onset to hospitalization, hospitalization time, urinary occult blood and levels of ALT, AST, total bilirubin, LDH, and PCT were positively correlated with severe malaria (r > 0, all P < 0.05), while red blood cell count, platelet count and albumin level were negatively correlated with severe malaria (r < 0, all P < 0.05). Among them, platelet count was a good indicator of malaria severity (|r| ≥ 0.5, P < 0.01). Urinary occult blood, AST, total bilirubin, LDH, serum creatinine, urea nitrogen and PCT were risk factors for severe malaria (OR > 1, P < 0.05), while red blood cell count, platelet count, hemoglobin and albumin level were protective factors against severe malaria (OR < 1, P < 0.05). Platelet count and total bilirubin level were independent impact factors for the progression of malaria patients to severe cases (P < 0.05), with AUCs of 0.867 and 0.769, respectively. The AUC for the combined detection of the both was 0.900, which was higher than that for single indicator detection (P < 0.01). Conclusion Platelet count and total bilirubin level can serve as independent impact factors for early warning of severe malaria. Combined detection is more helpful than single detection for early warning of severe malaria.
Key words: Malaria; Imported; Severe illness; Influencing factors; Early warning
| [1] | Varo R, Chaccour C, Bassat Q. Update on malaria[J]. Med Clin (Barc), 2020, 155(9): 395-402. |
| [2] | Yin JH, Lengeler C, Tanner M, et al. A malaria-free China: global importance and key experience[J]. Adv Parasitol, 2022, 116: xv-xix. |
| [3] | Feng J, Tu H, Zhang L, et al. Imported malaria cases: China, 2012-2018[J]. China CDC Weekly, 2020, 2(17): 277-283. |
| [4] | Zhang T, Jiang JJ, Lyu XF, et al. Surveillance and response to imported malaria during the COVID-19 epidemic―Anhui Province, China, 2019-2021[J]. China CDC Weekly, 2022, 4(28): 622-625. |
| [5] | Balerdi-Sarasola L, Mu?oz J, Fleitas P, et al. Not all severe malaria cases are severe: is it time to redefine severity criteria for malaria in non-endemic regions?[J]. Travel Med Infect Dis. 2024, 60: 102740. |
| [6] | World Health Organization. WHO Guidelines for malaria[EB/OL]. (2022-02-18)[2024-06-14]. https://www.who.int/. |
| [7] | Expert Group of National Center for Infectious Diseases. Guidelines for malaria diagnosis and treatment[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 419-427. (in Chinese) |
| (国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427.) | |
| [8] | Yi J, Wu DN, Dong XR, et al. Analysis of laboratory detection capability for imported malaria in Hubei Province before and after malaria elimination[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 177-181, 190. (in Chinese) |
| (易佳, 吴冬妮, 董小蓉, 等. 湖北省消除疟疾前后输入性疟疾实验室检测能力分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 177-181, 190.) | |
| [9] | Balaji SN, Deshmukh R, Trivedi V. Severe malaria: biology, clinical manifestation, pathogenesis and consequences[J]. J Vector Borne Dis, 2020, 57(1): 1-13. |
| [10] | Venkatesan P. The 2023 WHO World malaria report[J]. Lancet Microbe, 2024, 5(3): e214. |
| [11] | Wen J, Guo MQ, Zhang B, et al. Epidemiological analysis of imported malaria in Shanghai Public Health Clinical Center from 2012 to 2022[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 147-152. (in Chinese) |
| (文静, 郭明权, 张蓓, 等. 2012—2022年上海市公共卫生临床中心输入性疟疾病例流行病学分析[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 147-152.) | |
| [12] | Zhuang SF, Li ZX, Peng JP, et al. Evaluation on malaria elimination process and strategy in Hunan Province[J]. Pract Prev Med, 2022, 29(11): 1281-1285. (in Chinese) |
| (庄世锋, 李正祥, 彭进平, 等. 湖南省消除疟疾历程及策略评价[J]. 实用预防医学, 2022, 29(11): 1281-1285.) | |
| [13] | Chen F, He JA, Dong RL, et al. Application of SPR protein chip in screening for imported malaria[J]. Chin J Biotechnol, 2021, 37(4): 1360-1367. (in Chinese) |
| (陈凡, 何建安, 董瑞玲, 等. SPR蛋白质芯片在输入性疟疾筛查中的应用[J]. 生物工程学报, 2021, 37(4): 1360-1367.) | |
| [14] | Zhang X, Ruan W, Wang XX, et al. Epidemiological characteristics of imported severe malaria cases in Zhejiang Province from 2012-2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(4): 466-472. (in Chinese) |
| (张轩, 阮卫, 王笑笑, 等. 浙江省2012—2020年输入性疟疾重症病例流行特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(4): 466-472.) | |
| [15] | Han CX, Sun AJ, Li YT, et al. Epidemiological and clinical characteristics of imported malaria in Dalian from 2013 to 2018[J]. Chin J Endem, 2019, 38(10): 835-839. (in Chinese) |
| (韩常新, 孙艾军, 李雨婷, 等. 2013—2018年大连市输入性疟疾的流行病学及临床特征分析[J]. 中华地方病学杂志, 2019, 38(10): 835-839.) | |
| [16] | Jin H, Huang L, Wang L. Analysis of risk factors associated with prolonged hospital stay for imported malaria cases in Chengdu[J]. Sichuan Med J, 2022, 43(1): 67-71. (in Chinese) |
| (金鸿, 黄亮, 王林. 成都市输入性疟疾患者住院时间延长危险因素分析[J]. 四川医学, 2022, 43(1): 67-71.) | |
| [17] | He ZY, Wang XM, Li X, et al. Comparative analysis of severe and general malaria cases in Beijing, 2013-2020[J]. Cap J Public Health, 2021, 15(4): 197-199. (in Chinese) |
| (何战英, 王小梅, 李旭, 等. 2013—2020年北京市重症和普通疟疾病例特征比较分析[J]. 首都公共卫生, 2021, 15(4): 197-199.) | |
| [18] | Xu Y, Wang LJ, Kong XL, et al. Epidemiological characteristics of imported malaria in Shandong Province in 2017-2022[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 140-146. (in Chinese) |
| (许艳, 王龙江, 孔祥礼, 等. 2017—2022年山东省输入性疟疾流行病学特征[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 140-146.) | |
| [19] | Groomes PV, Kanjee U, Duraisingh MT. RBC membrane biomechanics and Plasmodium falciparum invasion: probing beyond ligand-receptor interactions[J]. Trends Parasitol, 2022, 38(4): 302-315. |
| [20] | Antwi-Baffour S, Mensah BT, Johnson G, et al. Haematological parameters and their correlation with the degree of malaria parasitaemia among outpatients attending a polyclinic[J]. Malar J, 2023, 22(1): 281. |
| [21] | Gao XS, Guo J, Duan XF. Changes and clinical significance of the inflammatory markers in patients with malaria[J]. Chin J Exp Clin Infect Dis Electron Ed, 2018, 12(3): 240-243. (in Chinese) |
| (高学松, 郭江, 段雪飞. 疟疾患者炎症指标变化特点及临床意义[J]. 中华实验和临床感染病杂志(电子版), 2018, 12(3): 240-243.) | |
| [22] | Asare R, Opoku-Okrah C, Danquah KO, et al. Assessment of platelet indices and platelet activation markers in children with Plasmodium falciparum malaria[J]. Malar J, 2020, 19(1): 143. |
| [23] | Mita-Mendoza NK, Magallon-Tejada A, Parmar P, et al. Dimethyl fumarate reduces TNF and Plasmodium falciparum induced brain endothelium activation in vitro[J]. Malar J, 2020, 19(1): 376. |
| [24] | Cha SJ, Yu X, Gregory BD, et al. Identification of key determinants of cerebral malaria development and inhibition pathways[J]. mBio, 2022, 13(1): e0370821. |
| [25] | Shonhai A. The role of Hsp70s in the development and pathogenicity of Plasmodium falciparum[J]. Adv Exp Med Biol, 2021, 1340: 75-95. |
| [26] | Wu DN, Zhang HX, Zhu H, et al. Characteristics of imported malaria cases in Hubei Province from 2016 to 2020[J]. Chin J Parasitol Parasit Dis, 2021, 39(5): 585-591. (in Chinese) |
| (吴冬妮, 张华勋, 朱红, 等. 2016—2020年湖北省输入性疟疾病例特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2021, 39(5): 585-591.) | |
| [27] | Cao S, Wang L. Malaria epidemic situation and its control strategy from 1952 to 2018 in Yangpu District of Shanghai[J]. Shanghai J Prev Med, 2019, 31(11): 907-910. (in Chinese) |
| (曹慎, 王琳. 上海市杨浦区1952—2018年疟疾疫情和防治策略研究[J]. 上海预防医学, 2019, 31(11): 907-910.) |
/
| 〈 |
|
〉 |